Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RNS60 in Mild Asthma
NCT02422121Phase 2Completed
- Sponsor
- Revalesio Corporation
- Start
- Apr 2015
- Primary completion
- Nov 2015
- Modality
- Nanoparticles, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of RNS60 in asthma, sponsored by Revalesio Corporation. Started Apr 2015; status: completed.
02
Drugs
RNS60
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02422121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02422121.